文献速递泌尿生殖MR

3T血氧水平依赖MRI鉴别前列腺癌与良性组织:初步经验

Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience.
PubMed 文献 · Br J Radiol · 2021-07-08

研究纳入145例活检证实的前列腺癌患者,在3T行BOLD MRI获取R2*值。肿瘤R2*值(25.95 s-1)与良性外周带(27.83 s-1)及良性移行带(21.66 s-1)均有显著差异(p<0.001)。以R2* 22.8 s-1为阈值鉴别肿瘤的AUC为0.606,敏感度73.8%、特异度52%。

要点

  • 肿瘤R2*值显著低于良性外周带但高于良性移行带,需注意分区对比。
  • R2*鉴别肿瘤的AUC仅0.606,特异度52%,单独诊断价值有限。
  • R2*测量重复性以肿瘤(8.5%)和移行带(6.8%)较好,外周带变异较大(13.3%)。

核心结论

  • 3T BOLD MRI的R2*值在肿瘤、良性外周带和良性移行带间存在显著差异,可作为鉴别工具但临床直接应用尚需进一步研究。

研究设计与样本

  • 单中心前瞻性初步研究,纳入145例活检证实的前列腺癌患者。
  • 采用3T MRI多回波快速场回波序列采集12幅T2*加权图像,测量肿瘤及良性外周带、移行带的R2*值。

关键影像表现/征象

  • 肿瘤R2*值为25.95 s-1,良性外周带为27.83 s-1,良性移行带为21.66 s-1,三者差异有统计学意义(p<0.001)。
  • 肿瘤R2*值与Gleason评分、年龄、前列腺体积、PSA及肿瘤大小均无关联。

诊断标准与关键数值

  • 以R2*值22.8 s-1为最佳截断值鉴别前列腺癌与良性组织,AUC为0.606,敏感度73.8%,特异度52%。
  • Bland-Altman检验显示R2*测量的平均差异:肿瘤8.5%,良性外周带13.3%,良性移行带6.8%。

临床应用与阅片要点

  • 阅片时可参考R2*值辅助区分肿瘤与良性组织,但特异度低,不能替代常规序列。
  • 测量时注意外周带R2*变异较大,重复测量或结合其他序列可减少误差。

局限性

  • 原文指出需进一步研究才能直接临床应用于鉴别诊断。
  • 本研究为单中心初步经验,样本量和设计可能限制结论外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Blood oxygenation-level dependent (BOLD) MRI may identify or quantify the regional distribution of hypoxia within a tumor. We aimed to evaluate the feasibility of BOLD MRI at 3 T in differentiating prostate cancer from benign tissue.

METHODS: A total of 145 patients with biopsy-proven prostate cancer underwent BOLD MRI at 3 T. BOLD MRI was performed using a multiple fast field echo sequence to acquire 12 T2*-weighted images. The R2* value (rate of relaxation, s-1) was measured in the index tumor, and benign peripheral (PZ) and transition zone (TZ), and the results were compared. The variability of R2* measurements was evaluated.

RESULTS: Tumor R2* values (25.95 s-1) were significantly different from the benign PZ (27.83 s-1) and benign TZ (21.66 s-1) (p < 0.001). For identifying the tumor, the area under the receiver operating characteristic of R2* was 0.606, with an optimal cut-off value of 22.8 s-1 resulting in 73.8% sensitivity and 52% specificity. In the Bland-Altman test, the mean differences in R2* values were 8.5% for tumors, 13.3% for benign PZ, and 6.8% for benign TZ. No associations between tumor R2* value and Gleason score, age, prostate volume, prostate-specific antigen, or tumor size.

CONCLUSION: BOLD MRI at 3 T appears to be a feasible tool for differentiating between prostate cancer and benign tissue. However, further studies are required for a direct clinical application.

ADVANCES IN KNOWLEDGE: The R2* values are significantly different among prostate cancer, benign PZ, and benign TZ.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim Y, Park JJ, Kim CK, et al. Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience. Br J Radiol. 2021. PMID: 34235962. doi:10.1259/bjr.20210461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。